ZCT — Zero Candida Technologies Income Statement
0.000.00%
Last trade - 00:00- CA$3.91m
- CA$1.42m
Annual income statement for Zero Candida Technologies, fiscal year end - July 31st, CAD millions except per share, conversion factor applied.
2022 July 31st | 2023 July 31st | 2024 July 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||
| Other Operating Expenses | |||
| Total Operating Expenses | 0.046 | 0.011 | 0.006 |
| Operating Profit | -0.046 | -0.011 | -0.006 |
| Net Income Before Taxes | -0.046 | -0.011 | -0.006 |
| Net Income After Taxes | -0.046 | -0.011 | -0.006 |
| Net Income Before Extraordinary Items | |||
| Net Income | -0.046 | -0.011 | -0.006 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Diluted Net Income | -0.046 | -0.011 | -0.006 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | -0.002 | -0.001 | -0 |